MUFG Americas’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
– Sell
-41
Closed -$2K – 928
2017
Q4
$2K Sell
41
-25
-38% -$1.13K ﹤0.01% 959
2017
Q3
$3K Hold
66
– – ﹤0.01% 1000
2017
Q2
$3K Buy
+66
New +$3.38K ﹤0.01% 998
2016
Q2
– Sell
-142
Closed -$11K – 1150
2016
Q1
$11K Buy
+142
New +$11.2K ﹤0.01% 799

Other funds holding LRMR

MUFG Americas's LRMR Position: Q1 2018 in Review

MUFG Americas sold out of Larimar Therapeutics (LRMR) in Q1 2018, closing a stake of 41 shares — an estimated $2K sold.

MUFG Americas first reported a position in LRMR in Q1 2016 and held it in 4 quarters. The position peaked at $11K in Q1 2016. 61 funds tracked by Wall St. Rank hold LRMR as of Q1 2018.

  • MUFG Americas reported no remaining Larimar Therapeutics position as of Q1 2018 after selling out during the quarter.
  • MUFG Americas sold 41 Larimar Therapeutics shares in Q1 2018, an estimated $2K.
  • MUFG Americas first reported a position in Larimar Therapeutics in Q1 2016 and held it in 4 quarters.
  • MUFG Americas's Larimar Therapeutics position peaked at $11K in Q1 2016.
  • 61 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2018.

Based on MUFG Americas's 13F filing for Q1 2018, filed 7 May 2018.